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Cerebral Venous Thrombosis and Livedo Reticularis in a 
Case with MTHFR 677TT Homozygote
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Hyperhomocysteinemia associated with methylene terahydrofolate reductase (MTHFR) mutation can be a risk 
factor for idiopathic cerebral venous thrombosis. We describe the first case of MTHFR 677TT homozygote with 
cerebral venous thrombosis and livedo reticularis. A 45-year-old man presented with seizures and mottled-like skin 
lesions, that were aggravated by cold temperature. Hemorrhagic infarct in the right frontoparietal area with superior 
sagittal sinus thrombosis was observed. He had hyperhomocysteinemia, low plasma folate level, and MTHFR 677TT 
homozygote genotype, which might be associated with livedo reticularis and increase the risk for cerebral venous 
thrombosis.
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Hyperhomocysteinemia causes vascular endothelial 
damage that result in atherosclerosis and ischemic 
strokes.
1 It is also associated with prothrombotic state or 
venous thromboembolism
2 including cerebral venous 
thrombosis.
3 Among the thrombophilic factors with 
hyperhomocysteinemia, methylene tetrahydrofolate reduc-
tase (MTHFR) mutant (C677 →T, homozygote) with 
low plasma folate concentration increases the risk for 
cerebral venous thrombosis.
4 MTHFR 677TT is thermo-
labile and sensitive to temperature alteration.
5
Livedo reticularis is a skin lesion caused by hyper-
viscosity in venules.
6 It often reflects hypercoagulable 
states such as cryoglobulinemia or cold agglutininemia.
6 
However, livedo reticularis with hyperhomocysteinemia 
or cerebral venous thrombosis is unknown.
We experienced the first case of livedo reticularis and 
MTHFR 677TT mutant presenting with seizures and 
venous infarct due to cerebral venous thrombosis.
CASE REPORT
A 45 year-old man was brought to the emergency 
room with uncontrolled seizures. Two days ago, sudden 
paresthesia in left arm developed, which progressed to 
tonic posturing and leftward head version, followed by 
a generalized tonic clonic seizure. In the emergency 
room, he was drowsy but blood pressure was 131/84 
mmHg with heart rate of 86, respiratory rate 18, and 
body temperature 36.6℃. Other physical findings 
including chest or abdomen revealed no abnormalities. 
However, mottled bluish discolorations of skin were 
noted in all extremities, more prominent in both legs and 
buttock areas (Fig. 1). Neurologic examination showed Journal of Clinical Neurology: Vol. 2, No. 2, 2006
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Figure 2. MR images of the patient. 
Diffusion MRI (A) and ADC map (B) 
showed vasogenic and cytotoxic edemas 
on the right frontoparietal lobes which 
were hemorrhagic infarctions with surroun-
ding edema (C). Brain venography showed
filling defects in the superior sagittal sinus,
suggesting thrombosis (D).
Figure 1. A mottled, net-lke purplish discolorations of both legs
suggesting livedo reticularis, which aggravated with cold 
temperature, but did not disappear after warming-up or elevation 
of limbs.
bilateral gaze-evoked nystagmus. Mild weakness in 
muscle power was noted in the left extremities, but 
sensory seemed to be symmetric to painful stimuli. Deep 
tendon reflexes were hyperactive in both sides. Neck 
was supple and carotid or ophthalmic bruits were not 
audible.
T2-weighted MR images showed heterogeneous 
signals in the right frontal and parietal lobes involving 
cortical and subcortical regions. Diffusion-weighted 
images indicated that the lesions were due to both 
vasogenic and cytotoxic edema. MR venography showed 
filling defect in superior sagittal sinus (Fig. 2).
The laboratory findings showed hyperhomocysteinemia 
with plasma homocysteine level of 25.7umol/L (normal 
range 5~15 umol/L). Low plasma level of folate was 
also detected (2.2 ng/mL, normal range 3~15 ng/mL). 
He had MTHFR homozygote mutation (C677 →T) in 
genetyping analysis. Vitamin B12 level, and other 
prothrombotic factors such as plasma protein C, S, or 
antithrombin III levels were normal. Cryoglobulin cold 
agglutinin, dysfibrinogenemia, activated protein C resis-
tance, prothrombin gene mutation, antineutrophilic cyto-
plasmic antibody, antinuclear antibody, anti-double strand 
DNA antibody, lupus anticoagulants, anticardiolipin anti-
body, or evidence for disseminated intravascular coagu-
lation (DIC) were all negative.
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and switched to warfarin at the time of discharge. He 
also received anticonvulsant, carbamazepine 400 mg/day, 
and supplements of folate, cobalamine and pyridoxine. 
He was recovered after the treatment without neuro-
logical deficit.
DISCUSSION
We first report a case of cerebral venous thrombosis 
and livedo reticularis in thrombophilic state with hyper-
homocysteinemia and MTHFR 677TT. There was a 
report with cerebellar infarction and hyperhomocysteine-
mia having MTHFR 677TT and CBS 1080TT mutant.
7 
However, cerebral venous thrombosis associated with 
MTHFR 677TT genotype has not been reported.
There are several reports with cerebral venous 
thrombosis, related to the thrombophilic state, such as 
protein C or antithrombin III deficiency or paroxysmal 
nocturnal hemoglobinuria.
9,10,11 However, cerebral venous 
thrombosis with hyperhomocysteinemia has been reported 
in one case, in which the patient had homocysteinuria 
and superior sagittal sinus thrombosis.
8
Hyperhomocysteinemia is the newly recognized 
causes of cerebral venous thrombosis. It represents 
approximately 30% of the cerebral venous thrombosis.
12 
In addition to the factor V Leiden and prothrombin gene 
mutation (PTHRA
20210), hyperhomocysteinemia is fre-
quently observed in patients with cerebral venous 
thrombosis when compared to that of controls (43.3% 
versus 10%).
12 The mechanism of venous thrombosis by 
hyperhomocysteinemia is unknown. It has been suggested 
that homocysteine has direct effect on the vascular 
endothelium and the clotting cascade.
13,14 Genetic and 
nutritional factors are also important in hyperhomo-
cysteinemia.
4 Low folate, vitamin B12 or B6 deficiencies 
are prone to have hyperhomocysteinemia, especially in 
patient with the MTHFR thermolabile mutant. In our 
case, the patient had been predisposed to prothrombic 
state in mild folate deficiency. The mutation of C →T 
at nucleotide position 677 of the MTHFR gene is 
responsible for a lower synthesis of methyl-tetra-
hydrofolate from methylene-tetrahydrofolate.
15 Because 
methyl-tetrahydrofolate is a methyl donor in the methy-
lation reaction of homocysteine to methionine, a 
decrease of MTHFR activity may result in homocysteine 
accumulation.
15 
This patient showed livedo reticularis, which might 
reflect systemic hypercoagulable states such as thrombo-
cythemia, cryoglobulinemia, cold agglutininemia, lupus 
erythematosus, anticardiolipin syndrome, disseminated 
intravascular coagulation, leukemia, or vascular obstruc-
tive diseases in arterioles or venules such as thrombo-
emboli, polyarteritis nodosa, rheumatoid vasculitis, 
livedoid vasculitis, and Sneddon’s syndrome.
6 In this 
case, the patient had a history of livedo reticularis prior 
to the thrombotic event. The supporting evidence of 
other systemic causes for livedo reticularis were absent 
on the laboratory tests. We can infer that the livedo 
reticularis may predict a risk of cerebral venous throm-
bosis, although whether it directly cause cerebral venous 
thrombosis remains unknown.
We report the first case of cerebral venous thrombosis 
associated with MTHFR 677TT mutant in Korea. Livedo 
reticularis may reflect prothrombotic state caused by 
hyperhomocysteinemia, which resulted in cerebral 
venous thrombosis. It is worth screening for the throm-
bophilic conditions including skin lesion, homocysteine, 
plasma folate and MTHFR gene mutation for idiopathic 
cerebral venous thrombosis especially in young patients. 
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